ISRCTN16751129CompletedNot Applicable
Capsaicinoids reduces appetite response: an open label study in free living population
OmniActive Health Technologies Ltd.0 sites150 target enrollmentStarted: January 24, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 150
Study Overview
Brief Summary
2017 results in: https://www.ecronicon.com/ecnu/pdf/ECNU-07-0000219.pdf
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged between 19-51 years
- •2. BMI of less than 40kg/m2
- •3. Provision of written informed consent
Exclusion Criteria
- •1. Chronic disease/condition
- •2. Pregnancy or lactation
- •3. No dietary supplement consumption
Investigators
Similar Trials
Completed
Not Applicable
Capsaicinoids supplementation effect on appetite and body composition in healthy men and womeAffects of of consumption of capsaicinoidsNutritional, Metabolic, EndocrineISRCTN10458693OmniActive Health Technologies Inc40
Withdrawn
Not Applicable
Capsaicinoid Ingestion, Human Metabolism and ExerciseMetabolismNCT02139852University of Prince Edward Island
Withdrawn
Not Applicable
Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)MetabolismExerciseNCT02138630University of Prince Edward Island
Completed
Not Applicable
Capsaicinoids Enhance Metabolic Rate – An Open Label StudyISRCTN13980309OmniActive Health Technologies Ltd.40
Not yet recruiting
Phase 3
The effect of Coleus forskohlii extract on the risk factors of metabolic syndromeMetabolic syndromeDiet and Nutrition - ObesityAlternative and Complementary Medicine - Herbal remediesMetabolic and Endocrine - Metabolic disordersObesityACTRN12614000305628Victoria University50